Clinical Trials · NCT06559722
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Enrollment
- 510
- Start date
- Aug 2024
- Locations
- See registry
- Primary endpoint
- Change from baseline in HbA1c after 26 weeks of treatment